Genmab News

Genmab News

Date Title View
May 14, 2020
Genmab Announces Data to be Presented at the EHA25 Virtual Congress
200514_i07_MR_EHA_Abstracts
May 13, 2020
Genmab A/S has published its Articles of Association
Articles of Association - May 12, 2020 (UK)
May 12, 2020
Capital Increase in Genmab as a Result of Employee Warrant Exercise
200512_CA21_Warrant Exercise
May 06, 2020
Genmab Announces Financial Results for the First Quarter of 2020
060520_CA20_Q1 2020 Interim Report
May 01, 2020
Genmab Announces U.S. FDA Approval of Subcutaneous Formulation of Daratumumab, DARZALEX FASPRO™ (daratumumab and hyaluronidase-fihj), for the Treatment of Patients with Multiple Myeloma
010520_CA19_DARZALEX FASPRO US Approval
Apr 30, 2020
CHMP Issues Positive Opinion Recommending Subcutaneous Formulation of Daratumumab for the Treatment of Patients with Multiple Myeloma
300420_CA18_Dara SC CHMP Opinion
Apr 29, 2020
Genmab Announces Data to be Presented at ASCO20 Virtual Scientific Program
290420_i06_ASCO20
Apr 14, 2020
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2020
140420_CA17_Dara Q1 20 Sales
Apr 01, 2020
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
010420_CA16_Managerial Employees Transactions
Apr 01, 2020
Genmab A/S has published its Articles of Association
Articles of Association - March 31 2020 (UK)
Mar 31, 2020
Capital Increase in Genmab as a Result of Employee Warrant Exercise
200331_CA15_Warrant Exercise
Mar 30, 2020
Genmab A/S has published its Articles of Association
Articles of Association - March 26 2020 (UK)
Mar 30, 2020
Genmab Files Annual Report with the U.S. Securities and Exchange Commission
300320_i05_20F Filing
Mar 26, 2020
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
260320_CA14_Managerial Employee Transactions
Mar 26, 2020
Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to the New Member of the Board of Directors and a New Member of Management, and Grant of Restricted Stock Units and Warrants to Employees and a New Member
260320_CA13_Constitution of the Board and grant of RSUs and Warrants
Mar 26, 2020
Passing of Genmab A/S’ Annual General Meeting
260320_CA12_AGM Passing
Mar 12, 2020
Genmab A/S Provides Update to Annual General Meeting
200312_i04_AGM Update
Mar 10, 2020
Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer
100320_CA11_COO
Feb 27, 2020
Notice to Convene the Annual General Meeting of Genmab A/S
200227_CA10_Genmab 2020 AGM Calling with Agenda and Appendices
Feb 26, 2020
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
260220_CA09_Man Empl Transaction (Sale of Shares)
Feb 26, 2020
Genmab A/S has published its Articles of Association
Articles of Association - February 25, 2020 (UK)
Feb 25, 2020
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
250220_CA08_Man Empl Transaction (Warrant Exercise)
Feb 25, 2020
Capital Increase in Genmab as a Result of Employee Warrant Exercise
250220_CA07_Warrant Exercise
Feb 24, 2020
U.S. FDA Filing Acceptance and Priority Review for sBLA, Submitted by Novartis, for Ofatumumab in Relapsing Multiple Sclerosis
240220_i03_Ofa SC Acceptances
Feb 21, 2020
Genmab Board of Directors Chairman to Step Down
210220_CA06_Board of Directors